22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
Registration is open for an upcoming OSHA meeting on the benefits of using leading indicators in add...
Read More >
Gail Peace started her business journey early. At 12 - having never worn makeup - she began selling ...
Read More >
Twenty-four states, 48 cities and counties and Washington D.C. will increase their minimum hourly wa...
Read More >
As businesses around the world continue to adapt to new day-to-day realities and challenges brought ...
Read More >
On July 17, 2019, the Supreme Court of Ohio announced a major victory for the Ohio construction indu...
Read More >
On June 13, 2019, the Internal Revenue Service (IRS), Department of Labor and Department of Health a...
Read More >